Liver transplantation for hepatocellular carcinoma: The best treatment, but for which patient?
β Scribed by M E Schwartz
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 188 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
propranolol in the prevention of variceal re-bleeding: preliminary results hemodynamics, that may identify subgroups of patients at of a multicenter randomized trial [Abstract]. HEPATOLOGY 1995;22:297A. high risk for hepatic deterioration and early mortality precip-14. Jalan R, Forrest EH, Redhead DN, Dillon JF, Bzeizi KI, Finlayson NDC, itated by TIPS.
MacGilchrist AJ, et al. TIPSS vs variceal band ligation in the secondary prevention of variceal hemorrhage in cirrhosis: preliminary results of a Cost is an increasingly important consideration in the randomized, controlled study [Abstract]. HEPATOLOGY 1995;22:251A.
π SIMILAR VOLUMES
The new allocation policy of the United Network of Organ Sharing (UNOS) based on the model for end-stage liver disease (MELD) gives candidates with stage T1 or stage T2 hepatocellular carcinoma (HCC) a priority MELD score beyond their degree of hepatic decompensation. The aim of this study was to de
In regions with a limited deceased donor pool, living donor adult liver transplantation (LDALT) has become an important treatment modality for patients with hepatocellular carcinoma (HCC) and cirrhosis. Studies have shown higher recurrence rates of HCC after LDALT in comparison with deceased donor l
The purposes of cancer staging are (1) to accurately predict a patient's prognosis and (2) to determine the appropriate interventions. Hepatocellular carcinoma (HCC) is somewhat unique: it usually affects patients with underlying liver disease, and both tumor burden and liver function need to be car